Yokukansan normalizes glucocorticoid receptor protein expression in oligodendrocytes of the corpus callosum by regulating microRNA-124a expression after stress exposure

Brain Research Bulletin

Volumn 114, Issue , 2015, Pages 49-55

  Shimizu, Shoko ^a   Tanaka, Takashi ^a   Tohyama, Masaya ^a,b   Miyata, Shingo ^a  

^a KINKI UNIVERSITY   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

Author keywords

Corpus callosum; Glucocorticoid receptor; HPA axis; MicroRNA; Stress responses; Yokukansan

Indexed keywords

CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; KAMPO; MICRORNA; MICRORNA 124A; MICRORNA 18; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; UNCLASSIFIED DRUG; YOKUKANSAN; CENTRAL NERVOUS SYSTEM AGENTS; GLUCOCORTICOID; HERBACEOUS AGENT; MESSENGER RNA; MIRN124 MICRORNA, MOUSE; MIRN124 MICRORNA, RAT; MIRN18 MICRORNA, MOUSE; MIRN18 MICRORNA, RAT; YI-GAN SAN;

ACUTE STRESS; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; CORTICOSTERONE BLOOD LEVEL; DOWN REGULATION; GENE EXPRESSION; GENETIC REGULATION; MALE; MOUSE; NONHUMAN; OLIGODENDROCYTE CULTURE; OLIGODENDROGLIA; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; ACUTE DISEASE; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; DRUG THERAPY; GENE EXPRESSION REGULATION; MENTAL STRESS; METABOLISM;

ACUTE DISEASE; ANIMALS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM AGENTS; CORPUS CALLOSUM; CORTICOSTERONE; DEXAMETHASONE; DOWN-REGULATION; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; MALE; MICE, INBRED C57BL; MICRORNAS; OLIGODENDROGLIA; RATS; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; STRESS, PSYCHOLOGICAL;

EID: 84927724484     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2015.03.007     Document Type: Article

References (59)

1. Agirre X., Vilas-Zornoza A., Jiménez-Velasco A., Martin-Subero J.I., Cordeu L., Gárate L., San, José-Eneriz E., Abizanda G., Rodríguez-Otero P., Fortes P., Rifón J., Bandrés E., Calasanz M.J., Martín V., Heiniger A., Torres A., Siebert R., Román-Gomez J., Prósper F. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res. 2009, 69(10):4443-4453.
2. Aguilera G., Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axisis: implication for stress adaptation. Egul. Pept. 2000, 96:23-29.
3. Bartanusz V., Jezova D., Bertini L.T., Tilders F.F., Aubery J.M., Kiss J.Z. Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypothalamic paraventricular neurons. Endocrinology 1993, 132:895-902.
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
5. Bian S., Xu T.L., Sun T. Tuning the cell fate of neurons and glia by microRNAs. Curr. Opin. Neurobiol. 2013, 23(6):928-934.
6. Boyle M.P., Brewer J.A., Funatsu M., Wozniak D.F., Tsien J.Z., Izumi Y., Muglia L.J. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc. Natl. Acad. Sci. USA 2005, 102(2):473-478.
7. Cao X., Yeo G., Muotri A.R., Kuwabara T., Gage F.H. Noncoding RNAs in the mammalian central nervous system. Annu. Rev. Neurosci. 2006, 29:77-103.
8. Carthew R.W. Gene regulation by microRNAs. Curr. Opin. Genet. Dev. 2006, 16(2):203-208.
9. Chen Y., Balasubramaniyan V., Peng J., Hurlock E.C., Tallquist M., Li J., Lu Q.R. Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat. Protocols 2007, 2:1044-1051.
10. Chiu H., Alqadah A., Chang C. The role of microRNAs in regulating neuronal connectivity. Front. Cell Neurosci. 2014, 7:283.
11. Dalmay T. MicroRNAs and cancer. J. Intern. Med. 2008, 263:366-375.
12. De Kloet E.R., Reul J.M. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 1987, 12(2):83-105.
13. De Kloet E.R., Joëls M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6(6):463-475.
14. DeRijk R.H., Schaaf M., Stam F.J., de Jong I.E., Swaab D.F., Ravid R., Vreugdenhil E., Cidlowski J.A., De Kloet E.R., Lucassen P.J. Very low levels of the glucocorticoid receptor beta isoform in the human hippocampus as shown by Taqman RT-PCR and immunocytochemistry. Brain Res. Mol. Brain Res. 2003, 116(1-2):17-26.
15. Durairaj R.V., Koilmani E.R. Environmental enrichment modulates glucocorticoid receptor expression and reduces anxiety in Indian field male mouse Mus booduga through up-regulation of microRNA-124a. Gen. Comp. Endocrinol. 2014, 199:26-32.
16. Gold P.W., Charney D.S. Diseases of the mental and brain: depression: a disease of the mind, brain, and body. Am. J. Psychiatry 2002, 159:1826.
17. Gräff J., Kim D., Dobbin M.M., Tsai L.H. Epigenetic regulation of gene expression in physiological and pathological brain processes. Physiol. Rev. 2011, 91(2):603-649.
18. Hayashi Y., Ishida Y., Inoue T., Udagawa M., Takeuchi K., Yoshimuta H., Kiue K., Ninomiya Y., Kawano J., Sameshima T., Kawahara T., Goto I., Shudo K., Kurayama S., Nakamura J., Okahara K., Mitsuyama Y. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:541-545.
19. Hiratsuka T., Matsuzaki S., Miyata S., Kinoshita M., Kakehi K., Nishida S., Katayama T., Tohyama M. Yokukansan inhibits neuronal death during ER stress by regulating the unfolded protein response. PLoS One 2010, 5(10):e13280.
20. Imamura S., Tabuchi M., Kushida H., Nishi A., Kanno H., Yamaguchi T., Sekiguchi K., Ikarashi Y., Kase Y. The blood-brain barrier permeability of geissoschizine methyl ether in Uncaria hook, a galenical constituent of the traditional Japanese medicine yokukansan. Cell Mol. Neurobiol. 2011, 31(5):787-793.
21. Iwasaki K., Satoh-Nakagawa T., Maruyama M., Monma Y., Nemoto M., Tomita N., Tanji H., Fujiwara H., Seki T., Fujii M., Arai H., Sasaki H. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J. Clin. Psychiatry 2005, 66:248-252.
22. Iwasaki K., Maruyama M., Tomita N., Furukawa K., Nemoto M., Fujiwara H., Seki T., Fujii M., Kodama M., Arai H. Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies. J. Clin. Psychiatry 2005, 66(12):1612-1613.
23. Iwasaki K., Takasaki K., Nogami A., Kubota K., Katsurabayashi S., Mishima K., Fujiwara M. Pharmacological studies for the ameliorative effects of yokukansan on memory deficits and abnormal behavior in an animal model of dementia. Folia Pharmacol. Jpn. 2012, 140:66-70.
24. Ji F., Lv X., Jiao J. The role of MicroRNAs in neural stem cells and neurogenesis. J. Genet. Genomics 2013, 40:61-66.
25. Kanno H., Kawakami Z., Mizoguchi K., Ikarashi Y., Kase Y. Yokukansan, a kampo medicine, protects PC12 cells from glutamate-induced death by augmenting gene expression of cystine/glutamate antiporter system Xc- PLoS One 2014, 9:e116275.
26. Kawanabe T., Yoritaka A., Shimura H., Oizumi H., Tanaka S., Hattori N. Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:284-287.
27. Kendler K.S., Karkowski L.M., Prescott C.A. Causal relationship between stressful life events and the onset of major depression. Am. J. Psychiatry 1999, 156:837-841.
28. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
29. Kuang X., Wang L.F., Yu L., Li Y.J., Wang Y.N., He Q., Chen C., Du J.R. Ligustilide ameliorates neuroinflammation and brain injury in focal cerebral ischemia/reperfusion rats: involvement of inhibition of TLR4/peroxiredoxin 6 signaling. Free Radic. Biol. Med. 2014, 71:165-175.
30. Kumar R., Thompson E.B. Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions. Mol. Endocrinol. 2003, 17(1):1-10.
31. Kushida H., Fukutake M., Tabuchi M., Katsuhara T., Nishimura H., Ikarashi Y., Kanitani M., Kase Y. Simultaneous quantitative analyses of indole and oxindole alkaloids of Uncaria Hook in rat plasma and brain after oral administration of the traditional Japanese medicine Yokukansan using high-performance liquid chromatography with tandem mass spectrometry. Biomed. Chromatogr. 2013, 27(12):1647-1656.
32. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002, 12:735-739.
33. Liu Y., Nakamura T., Toyoshima T., Lu F., Sumitani K., Shinomiya A., Keep R.F., Yamamoto T., Tamiya T., Itano T. Ameliorative effects of yokukansan on behavioral deficits in a gerbil model of global cerebral ischemia. Brain Res. 2014, 1543:300-307.
34. Matsuda Y., Kishi T., Shibayama H., Iwata N. Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials. Hum. Psychopharmacol. 2013, 28:80-86.
35. Matsumoto K., Zhao Q., Niu Y., Fujiwara H., Tanaka K., Sasaki-Hamada S., Oka J. Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence. J. Pharmacol. Sci. 2013, 122(4):257-269.
36. Matsusue Y., Horii-Hayashi N., Kirita T., Nishi M. Distribution of corticosteroid receptors in mature oligodendrocytes and oligodendrocyte progenitors of the adult mouse brain. J. Histochem. Cytochem. 2014, 62(3):211-226.
37. McEwen B.S. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann. N.Y. Acad. Sci. 2004, 1032:1-7.
38. Miyata S., Koyama Y., Takemoto K., Yoshikawa K., Ishikawa T., Taniguchi M., Inoue K., Aoki M., Hori O., Katayama T., Tohyama M. Plasma corticosterone activates SGK1 and induces morphological changes in oligodendrocytes in corpus callosum. PLoS One 2011, 6(5):e19859.
39. Miyata S., Hattori T., Shimizu S., Ito A., Tohyama M. Disturbance of oligodendrocyte function plays a key role in the pathogenesis of schizophrenia and major depressive disorder. Biomed. Res. Int. 2015, 2015:492367.
40. Mizukami K., Asada T., Kinoshita T., Tanaka K., Sonohara K., Nakai R., Yamaguchi K., Hanyu H., Kanaya K., Takao T., Okada M., Kudo S., Kotoku H., Iwakiri M., Kurita H., Miyamura T., Kawasaki Y., Omori K., Shiozaki K., Odawara T., Suzuki T., Yamada S., Nakamura Y., Toba K. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int. J. Neuropsychopharmacol. 2009, 12(2):191-199.
41. Myers B., McKlveen J.M., Herman J.P. Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress. Front. Neuroendocrinol. 2014, 35(2):180-196.
42. Nagata K., Yokoyama E., Yamazaki T., Takano D., Maeda T., Takahashi S., Terayama Y. Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial. Phytomedicine 2012, 19:524-528.
43. Nishi A., Yamaguchi T., Sekiguchi K., Imamura S., Tabuchi M., Kanno H., Nakai Y., Hashimoto K., Ikarashi Y., Kase Y. Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin 1A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan. Neuroscience 2012, 207:124-136.
44. Okahara K., Ishida Y., Hayashi Y., Inoue T., Tsuruta K., Takeuchi K., Yoshimuta H., Kiue K., Ninomiya Y., Kawano J., Yoshida K., Noda S., Tomita S., Fujimoto M., Hosomi J., Mitsuyama Y. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:532-536.
45. Reul J.M., De Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117(6):2505-2511.
46. Schaaf M.J., Cidlowski J.A. Molecular mechanisms of glucocorticoid action and resistance. J. Steroid Biochem. Mol. Biol. 2002, 83(1-5):37-48.
47. Shimizu S., Koyama Y., Hattori T., Tachibana T., Yoshimi T., Emoto H., Matsumoto Y., Miyata S., Katayama T., Ito A., Tohyama M. DBZ, a CNS-specific DISC1 binding protein, positively regulates oligodendrocyte differentiation. Glia 2014, 62(5):709-724.
48. Shinno H., Kamei M., Nakamura Y., Inami Y., Horiguchi J. Successful treatment with Yi-Gan San for rapid eye movement sleep behavior disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(7):1749-1751.
49. Silverman M.N., Sternberg E.M. Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann. NY Acad. Sci. 2012, 1261:55-63.
50. Stefani G., Slack F.J. Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell. Biol. 2008, 9:219-230.
51. Tabuchi M., Imamura S., Kawakami Z., Ikarashi Y., Kase Y. The blood-brain barrier permeability of 18β-glycyrrhetinic acid, a major metabolite of glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine yokukansan. Cell. Mol. Neurobiol. 2012, 32(7):1139-1146.
52. Tohyama, M., Miyata, S., Hattori, T., Shimizu, S., Matsuzaki, S., in press. Molecular basis of major psychiatric diseases such as schizophrenia and depression. Anat. Sci. Int.
53. Tsuji M., Takeuchi T., Miyagawa K., Ishii D., Imai T., Takeda K., Kitajima M., Takeda H. Yokukansan, a traditional Japanese herbal medicine, alleviates the emotional abnormality induced by maladaptation to stress in mice. Phytomedicine 2014, 21(3):363-371.
54. Uchida S., Nishida A., Hara K., Kamemoto T., Suetsugi M., Fujimoto M., Watanuki T., Wakabayashi Y., Otsuki K., McEwen B.S., Watanabe Y. Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. Eur. J. Neurosci. 2008, 27(9):2250-2261.
55. Vielkind U., Walencewicz A., Levine J.M., Bohn M.C. Type II glucocorticoid receptors are expressed in oligodendrocytes and astrocytes. J. Neurosci. Res. 1990, 27(3):360-373.
56. Vreugdenhil E., Verissimo C.S., Mariman R., Kamphorst J.T., Barbosa J.S., Zweers T., Champagne D.L., Schouten T., Meijer O.C., De Kloet E.R., Fitzsimons C.P. MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 2009, 150(5):2220-2228.
57. Wang Y., Stricker H.M., Gou D., Liu L. MicroRNA: past and present. Front. Biosci. 2007, 12:2316-2329.
58. Xin J., Zhang J., Yang Y., Deng M., Xie X. Radix Angelica Sinensis that contains the component Z-ligustilide promotes adult neurogenesis to mediate recovery from cognitive impairment. Curr. Neurovasc. Res. 2013, 10(4):304-315.
59. Zhu X., Chen C., Ye D., Guan D., Ye L., Jin J., Zhao H., Chen Y., Wang Z., Wang X., Xu Y. Diammonium glycyrrhizinate upregulates PGC-1α and protects against Aβ1-42-induced neurotoxicity. PLoS One 2012, 7(4):e35823.